REQUEST A DEMO
Total
USD $0.00
Search more companies

Teva Pharma EAD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Teva Pharma EAD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Teva Pharma EAD is a manufacturer of generic and bio-pharmaceutical products. The company offers a range of medications and healthcare products. Teva Pharma EAD claims to target healthcare providers, patients, and caregivers worldwide.

Headquarters
ul. Lyuba Velichkova 9
Sofia; Sofia - city; Postal Code: 1407

Contact Details: Purchase the Teva Pharma EAD report to view the information.

Website: https://www.teva.bg/

Basic Information
Total Employees:
Purchase the Teva Pharma EAD report to view the information.
Outstanding Shares:
Purchase the Teva Pharma EAD report to view the information.
Registered Capital:
Purchase the Teva Pharma EAD report to view the information.
Financial Auditors:
Purchase the Teva Pharma EAD report to view the information.
Incorporation Date:
May 27, 1993
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Balkanpharma Troyan AD
98.32%
Balkanpharma Dupnitsa AD
98.05%
Company Performance
Financial values in the chart are available after Teva Pharma EAD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
-15.17%
Total operating revenue
5.01%
Net Profit (Loss) for the Period
-0.52%
Total assets
-52.74%
Total equity
-66.53%
Net Profit Margin
2.35%
Return on Equity (ROE)
19.42%
Quick Ratio
-4.61%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?